Azulfidine tablets formally included in the national health insurance catalog eketinib hydrochloride tablets belong to the health insurance coverage

Exactinib hydrochloride has been included in the national health insurance catalog, so you can be reimbursed for the cost of ectinib hydrochloride through health insurance if you meet the health insurance regulations.

Medicare reimbursement can only be made at the designated hospitals and pharmacies that are bound to our health insurance card or social security card. If you don't go to a designated medical institution to get medical treatment or buy medicine, you will not be reimbursed, or you will be reimbursed very little money.

When you activate your health insurance card or social security card, you will be able to bind the designated hospitals and pharmacies. The cities and provinces are different, so the number of designated hospitals and pharmacies that can be used for binding will not be the same.

Additionally, if we need to apply for long-term medical treatment in a different location, we need to re-bind not only the designated hospital but also the designated pharmacy.

After selecting the location, the place where we will seek medical treatment is the "two fixed points" we have selected, and we can choose whether to buy at the fixed-point medical institution or to buy drugs at a number of fixed-point pharmacies with a prescription.

It is really worth noting that the Medical Benefits Fund will not pay for expenses incurred by participants in non-selected designated medical institutions outside the scope of emergency and first aid.

The medicines that are included in the Basic Medical Insurance Drug List are those that are clinically necessary, safe and effective, reasonably priced, easy to use, and guaranteed to be available on the market.

The medicines in the Basic Medical Insurance Drug List are selected on the basis of the National Essential Drugs and are divided into two categories:

Drugs in the "Category A List": those that are essential for clinical treatment, widely used, with good therapeutic efficacy, and with a low price among the same kind of drugs.

Drugs in the "B list": drugs that can be used for clinical treatment, with good therapeutic effects, and with a slightly higher price than those in the "A list" in the same category.

The "Class A Catalog" is formulated by the state and shall not be adjusted; the "Class B Catalog" is formulated by the state and may be adjusted by provinces, autonomous regions and municipalities directly under the central government in accordance with the local economic level, medical assistance and medication habits, and the sum of the number of varieties and the number of reductions shall not be increased or decreased. The sum of the number of varieties shall not exceed 15% of the total number of drugs in the "Class B Catalog" developed by the State.